CervoMed Inc

:CRVO

4.34

-0.28 (-6.06%)

4:20:42 PM EDT: $4.55 +0.21 (+4.84%)

CervoMed Inc Stock, :CRVO

20 Park Plaza, Suite 424, Boston, Massachusetts 02216

United States of America

Phone: +1.617.7444400

Number of Employees: 13

http://www.cervomed.com

Description

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in 2001 and is headquartered in Boston, MA.